Answers are grounded in this paper and cite their sources.
Cross-sectional study evaluates sexual dysfunction in RRMS, indicating the need for routine screening.
Sexual dysfunction (SD), a prevalent yet underreported complication in multiple sclerosis (MS), significantly impacts quality of life. This cross-sectional study at Imam Reza Clinic, Shiraz University of Medical Sciences, evaluated SD prevalence in 80 relapsing-remitting MS (RRMS) patients (65 females and 15 males; mean age 38.7 years) compared to 80 demographically matched controls (61 females and 19 males; mean age 39.1 years). SD was assessed using the Female Sexual Function Index (FSFI) for females and the International Index of Erectile Function (IIEF) for males, alongside brain-focused MRI to examine morphological changes. Female RRMS patients had significantly lower FSFI scores (mean 21.80, SD 7.13) than controls (mean 27.86, SD 4.83; p < .001). FSFI scores negatively correlated with cerebrospinal fluid volume (r = −0.297, p = .016), disease duration (r = −0.319, p = .010), fatigue (r = −0.412, p = .001), and depression (r = −0.387, p = .002). Male RRMS patients showed lower IIEF scores (mean 64.40, SD 8.77) compared to controls (mean 73.21, SD 2.84; p = .0012), with positive correlations between IIEF scores and insular cortex volume (r = 0.576, p = .025), cerebellar grey matter volume (r = 0.727, p = .002), and total grey matter volume (r = 0.846, p < .001). Multivariate regression identified MRI measurements, disease duration, and fatigue as independent SD predictors ( p < .05). The high SD prevalence in RRMS, with distinct sex-specific neuroimaging correlates, highlights the need for routine SD screening and tailored interventions in MS care to improve patient outcomes.
No takes yet. Share an insight, caveat, or question.
Dousty et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: